Gentel, Van Andel Institute Claim New Tech For Early Cancer DiagnosisMadison, Wis.-based Gentel Biosciences, a leader in proteomics tools, and the Grand Rapids-based Van Andel Research Institute, a biomedical research institute, jointly announce today the granting of U.S. Patent 7,838,634 for a new method to profile changes in the glycosylation of proteins captured on the surface of an antibody array slide.
FDA OKs Two More Celiac Assays From Phadia
Best Winter Festivals In Metro Detroit
Thanksgiving Parade Guide

Watch & Listen